RANZCP homepage
Mood disorders
The RANZCP produced a Clinical Practice Guideline on Mood Disorders in 2015 and released an update in 2020.
In November 2022, a steering group was formed to oversee an external review of the evidence for long-term psychodynamic psychotherapy for the treatment of mood disorders.
Several independent consultancies responded to a request for quotation issued in April 2023, and the steering group is currently considering next steps.
Recent updates
March 2023
Review of evidence for long term psychodynamic psychotherapy in the treatment of mood disorders
May 2022
FAQs: Members’ Requisition General Meeting [Member login required]
Mood Disorders Psychodynamic Psychotherapy Evidence Review Steering Group
Professor Bruce Singh AM is the independent chair of the steering group.
The membership of the steering group includes:
- a senior clinical academic psychiatrist
- three Fellows with expertise and clinical experience in psychodynamic psychotherapy
- a Fellow with expertise in evidence-based practice
- a community member with lived experience.
Mood Disorders Psychodynamic Psychotherapy Evidence Review Steering Group Terms of Reference [PDF; 121 KB]
Clinical Practice Guideline
Mood-disorders-clinical-practice-guideline-2020
Additional guidance
Additional guidance on treatments for mood disorders:
- Electroconvulsive therapy (ECT)
- Repetitive transcranial magnetic stimulation (rTMS)
- Transcranial direct current stimulation (tDCS)
- Ketamine therapy
- Medicinal cannabis
- Psychotherapy conducted by psychiatrists
Webinars, podcasts and e-learning modules
- Psych Matters podcast - New Clinical Guidelines for Mood Disorders: Management of Bipolar Disorder (26 Feb 2021)
- Psych Matters podcast - New Clinical Guidelines for Mood Disorders: Management of Major Depressive Disorder and Treatment Non-Response (14 Feb 2021)
- Innovations in the 2020 RANZCP Clinical Practice Guideline for Mood Disorders – member login required
Community resources
Contact
